Patient Characteristics at Baseline (N=395)
| Characteristic | No. (%) or Mean ± SD (Range) [Median] |
|---|---|
| Sex | |
| Female | 170 (43.0) |
| Male | 225 (57.0) |
| Functional status | |
| Normal activity | 178 (45.1) |
| Symptoms but ambulatory | 150 (37.9) |
| Confined to bed or chair <50% of waking hours | 44 (11.1) |
| Confined to bed or chair ≥50% of waking hours | 20 (5.1) |
| Completely disabled—100% bedridden | 3 (0.8) |
| Type of lung cancer | |
| Squamous cell carcinoma | 77 (19.5) |
| Adenomatous carcinoma | 164 (41.5) |
| Other non–small cell carcinoma | 67 (17.0) |
| Small cell carcinoma | 58 (14.7) |
| Unknown | 29 (7.3) |
| Treatment | |
| Surgery with/without chemotherapy/radiation therapy | 113 (28.6) |
| Chemotherapy and/or radiation therapy | 254 (64.3) |
| No treatment | 28 (7.1) |
| Metastases | |
| Present at baseline | 128 (32.4) |
| Found during follow-up | 37 (9.4) |
| None | 230 (58.2) |
| Cancer stage | |
| Stage I | 56 (14.2) |
| Stage II | 33 (8.3) |
| Stage III | 119 (30.1) |
| Stage IV | 133 (33.7) |
| Not confirmed | 54 (13.7) |
| Age, years | 63.4 ± 9.5 (31–88) [64] |
| Education, years | 10.9 ± 3.9 (2–24) [11] |
| Intervals in care | |
| Investigation to diagnosis, weeks | 5.6 ± 8.0 (0–78) [3] |
| Diagnosis to first treatment, days | 29.0 ± 26.6 (0–140) [21] |